Tranexamic Acid
Pricing Report NDC 66993-121-30

Latest NADAC: $2.04605 per EA · Effective May 22, 2019 · Est. package price $61.38 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Tranexamic Acid (NDC 66993-121-30) is $2.04605 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 22, 2019.

As a provided by Prasco Laboratories, this medication is distributed in a 30 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.04605
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
May 22, 2019
Billable Units
30 EA
Estimated Package Price
$61.38
Data Status
As of May 29, 2019
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
66993-121-30
Description
30 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2014, the NADAC wholesale price for (NDC ) has moved within a range of $1.62948 to $4.03468 per EA. Over this 5 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.6295 - $4.0347
Market Volatility
147.61% Variance
Latest Trend
25.56%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
May 22, 2019 $2.04605 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2019 $1.62948 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 20, 2019 $1.79367 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 20, 2019 $2.06928 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 23, 2019 $1.83040 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 19, 2018 $1.93699 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 21, 2018 $2.06020 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $2.12414 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 19, 2018 $2.06897 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 22, 2018 $1.87843 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 18, 2018 $2.03400 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 20, 2018 $1.97611 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026